Press release
RNAi Therapeutics Market Business Insights of Leading Players, Forecast 2024-2031 | Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics.
RNAi Therapeutics Market
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/rnai-therapeutics-market
The Global RNAi Therapeutics Market is estimated to reach at a high CAGR 17.4% during the forecast period (2024-2031).
Market Overview:
The market for RNAi therapeutics is focused on the development of therapies that target and silence specific genes responsible for various diseases. Key drivers of this market include advances in genetic research, increasing investments in biotechnology, and the rising prevalence of genetic disorders and chronic diseases. RNAi therapies have shown potential in treating conditions such as cancer, cardiovascular diseases, and rare genetic disorders. Continued improvements in delivery mechanisms and clinical trial successes are expected to accelerate market growth and broaden treatment applications.
RNAi Therapeutics Market Segments:
The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.
By Type: Small Interfering RNAs (siRNA), MicroRNA (miRNA).
By Application: Oncology, Cardiovascular, Respiratory Disorders, Renal Diseases, Genetic Disorders, Neurodegenerative Disorders, Infectious Diseases, Others.
By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intradermal Injections, Intraperitoneal Injections, Others.
By End-User: Hospitals, Research and Academic Laboratories, Diagnostic Laboratories.
Research Process:
Both primary and secondary data sources have been used in the global RNAi Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Regional Assessment:
Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for RNAi Therapeutics market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.
In terms of geographical analysis, RNAi Therapeutics Market report provides an in-depth view of-
● Regional level break-up
● Leading growth rates
● Countries with the largest market share
● Market factors
● Latest developments
● Industry challenges
● Regulatory policies
● Player strategies
Competitive Evaluation:
The RNAi Therapeutics Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.
Companies covered in this report are:
Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation, Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics, Inc.
Get Customization in the report as per your requirements + Exclusive Bundle & Multi-User Discounts: https://datamintelligence.com/customize/rnai-therapeutics-market
Recent Developments:
In November 2017, Arcturus Therapeutics, a biotechnology company focused on developing RNA-based medicines, merged with Alcobra Ltd., a clinical-stage biopharmaceutical company. This strategic merger allowed Arcturus to strengthen its capabilities in RNA drug delivery and expand its pipeline of RNA-based therapeutics. The combined company aimed to leverage Alcobra's expertise in neurological diseases and Arcturus's cutting-edge lipid nanoparticle technology to advance innovative treatments. The merger facilitated the development of a diverse portfolio of therapeutics for various conditions, including rare genetic diseases and cancer.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, RNAi Therapeutics market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global RNAi Therapeutics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global RNAi Therapeutics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the RNAi Therapeutics Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
What does the report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
Unlock Year-End Savings! Get Up to 30% Off: https://www.datamintelligence.com/buy-now-page?report=rnai-therapeutics-market
Frequently Asked Questions:
● What is the expected growth rate of the global RNAi Therapeutics market for the forecast period?
● What are the key factors driving the growth of the global RNAi Therapeutics market?
● What are the emerging trends in RNAi Therapeutics market?
● What region/countries are expected to witness the highest growth in the RNAi Therapeutics Market?
● What Opportunities exist for startups and investors in the RNAi Therapeutics Market?
● What are the top challenges RNAi Therapeutics startup face during the initial stages?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi Therapeutics Market Business Insights of Leading Players, Forecast 2024-2031 | Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics. here
News-ID: 3752203 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Air Separation Plant Market Expansion at 5% CAGR: Cryogenic Distillation Powers …
Air Separation Plant Market size is growing at a CAGR of 5% during the forecast period 2024-2031
DataM Intelligence has published a new research report on "Air Separation Plant Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. .…
Medical Device Outsourcing Market Outlook: Strategic Partnerships, Offshoring to …
Medical Device Outsourcing Market size was valued at USD 1,27,048.5 million in 2023 and is estimated to reach USD 3,40,743.1 million by 2031, growing at a CAGR of 13.1% during the forecast period (2024-2031).
The Medical Device Outsourcing Market has been witnessing remarkable growth, driven by the increasing demand for cost-effective and efficient production of medical devices. Outsourcing in the medical device sector involves delegating manufacturing, assembly, testing, or regulatory…
Business Jets Market Grows from $102.69B to $254B by 2032 with 12% CAGR Fueled b …
Business Jets Market size reached US$ 102.69 billion in 2024 and is expected to reach US$ 254.26billion by 2032, growing with a CAGR of 12% during the forecast period 2025-2032.
The business jets market involves manufacturing, leasing, and sales of aircraft for corporate and private travel. Jets offer flexibility, reduced travel time, and privacy for executives. Market growth is fueled by rising corporate travel demand, economic growth, and technological advancements in…
Central Venous Catheters Market to Reach US$4.71Bn by 2033 at 5.1% CAGR | North …
The central venous catheters market size reached US$3.03Billion in 2024 from US$2.89Billionin 2023 and is expected to reach US$ 4.71Billion by 2033, growing at a CAGR of 5.1% from 2025 to 2033.
Market growth is fueled by rising ICU admissions exceeding 5 million annually in the US alone, increasing prevalence of chronic diseases like cancer and end-stage renal disease (over 800,000 patients in US), and advancements in antimicrobial-coated catheters to…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
